P637 Incidence rate and clinical outcome of severe COVID-19 in Inflammatory Bowel Disease patients in a population-based setting

BACKGROUND: The broad use of immunosuppressants and biologicals in Inflammatory Bowel Disease (IBD) patients increases the susceptibility to severe infections, and possibly COVID-19. Recently, in a Swedish population-based study it was suggested that IBD patients are at an increased risk of hospital...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Crohns Colitis
Hlavní autoři: Rezazadeh Ardabili, A, Creemers, R H, Jonkers, D M A E, Romberg-Camps, M J L, Pierik, M J, van Bodegraven, A A
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8194845/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjab076.757
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky